Interactive Kiosks Simulate Multiple Sclerosis Symptoms at Bengaluru Event

Quick Summary

• A unique initiative titled “Walk in my Shoes” was organized in Bengaluru on Friday to raise awareness about Multiple Sclerosis (MS).
• The event included sensory simulation kiosks designed to replicate MS symptoms such as loss of balance,blurry vision,motor impairment,and loss of sensitivity through tools like leg bands,snellen charts,and tremor-inducing wrist straps.
• Roche India collaborated wiht the Multiple Sclerosis Society of India (MSSI) for this initiative.
• rajan S., Chief communication Officer at Roche india, emphasized that such initiatives can foster empathy toward MS patients.
• Arun Moha, Vice President of MSSI Bengaluru shared his personal experiences with MS and highlighted that awareness about the illness is limited.

– he pointed out financial challenges for patients as an MRI scan costs ₹30,000-₹40,000 and annual injections can amount to ₹1.6 lakh without offering a cure but marginal symptom relief.

• Policy hurdles affecting care for MS patients where also discussed during the event.

Indian Opinion Analysis

The “Walk in my Shoes” initiative represents a pioneering effort to generate empathy and understanding toward those living with Multiple Sclerosis. By recreating sensory simulations of common MS symptoms, it bridges gaps between patient experience and public awareness. While fostering compassion is vital in combating stigma around invisible illnesses like MS, larger systemic issues persist-such as affordability barriers for diagnostic scans and treatment options. As Arun Moha raised concerns regarding these financial burdens alongside policy inefficiencies affecting access to care for many individuals across India’s socioeconomic spectrum.

In the context of healthcare policy reform in India-which has been evolving slowly-the challenges voiced at this event underline urgent attention necessary from lawmakers.Improved funding mechanisms or insurance inclusivity could help reduce inequalities faced by chronic disease sufferers who bear notable social and economic costs alone.

More targeted advocacy efforts might push not only increased support structures but comprehensive strategies ensuring equitable treatment access nationwide amidst wider public health needs spanning other diseases too.Read more:https://www.examplelink.com